New Delhi, October 1: The H1N1 influenza strain has emerged as the dominant flu virus detected in India, accounting for 75 per cent of influenza positive samples in the latest surveillance data from the World Health Organization (WHO), highlighting the continued importance of monitoring seasonal respiratory infections.
The findings are based on WHO surveillance data covering weeks 36 and 37 of 2026, corresponding to September 1-14, with the information updated on September 21. The data showed that A(H1N1)pdm09 represented three out of every four influenza-positive samples recorded in India during the period.
The proportion recorded in India was higher than the overall share of H1N1 among influenza-positive samples across the WHO South-East Asia region. Of 3,632 samples tested in the region, 817 were positive for influenza, giving an overall positivity rate of 22 per cent.
The surveillance figures indicate that influenza activity continues to require close observation as countries move through periods of changing weather and seasonal respiratory illness. The predominance of one strain in positive samples also provides health authorities with information that can support surveillance and preparedness measures.
A(H1N1)pdm09 is a seasonal influenza virus that can cause symptoms ranging from fever, cough and sore throat to more serious respiratory complications. While many otherwise healthy people recover without major complications, the risk of severe illness can be higher among certain vulnerable groups.
Medical experts have particularly highlighted older adults, pregnant women, young children and people living with underlying health conditions as groups that may require greater attention when influenza infections occur.
Dr Rommel Tickoo, senior director of internal medicine at Max Hospital, said H1N1 continues to circulate as a seasonal influenza strain and noted that vulnerable people face a greater risk of complications. He stressed the importance of vaccination, respiratory hygiene, appropriate testing and timely antiviral treatment for patients at higher risk.
The WHO data does not by itself indicate that every person with influenza in India has H1N1, but it shows that the strain constituted the majority of influenza-positive samples included in the surveillance period.
Influenza surveillance is important because different strains can circulate simultaneously and their prevalence can change over time. Health systems use such information to understand patterns of transmission and prepare healthcare facilities for possible increases in respiratory illness.
For the public, basic preventive measures remain relevant during periods of increased flu activity. These include maintaining hand hygiene, covering the mouth and nose while coughing or sneezing, avoiding close contact with people who are unwell and staying home when experiencing significant respiratory symptoms.
People belonging to high-risk groups should seek medical advice when symptoms are severe, persistent or accompanied by breathing difficulties or other warning signs. Doctors may consider antiviral medicines for patients at higher risk of complications, particularly when treatment is started early.
Vaccination remains another important component of influenza prevention. Seasonal flu vaccines are designed to protect against influenza viruses expected to circulate during a particular season. The exact vaccination recommendation can vary according to age, health status and national or clinical guidance.
The latest surveillance information also comes as health systems across India continue to expand their capacity for disease monitoring and public-health response. The Union Health Ministry has in recent weeks highlighted pandemic preparedness, patient safety and the strengthening of healthcare infrastructure as part of broader health-sector priorities.
The focus on influenza surveillance is particularly relevant because respiratory infections can place additional pressure on outpatient departments and hospitals when transmission increases. Monitoring the circulating strains allows public-health authorities and medical professionals to track changing patterns rather than relying solely on reported symptoms.
The WHO findings should therefore be viewed as surveillance information for a specific period rather than a measure of all influenza infections occurring across India. The samples included in surveillance do not represent every case in the country, and influenza activity can vary between regions and over time.
The current data nevertheless places H1N1 at the centre of India’s influenza surveillance picture for the period covered. Continued monitoring will be important to determine whether its dominance persists in subsequent reporting periods.
Health professionals have also stressed that people should not rely on self-medication, particularly when symptoms become severe or when the patient has an existing medical condition. Early medical evaluation can help identify patients who may require closer monitoring or specific treatment.
As India moves further into the seasonal period associated with respiratory illnesses, the latest WHO surveillance figures provide a timely reminder of the need for preventive practices and awareness. The data also underlines the role of continued laboratory surveillance in identifying which influenza viruses are circulating and informing public health preparedness.
For families, the key concern remains recognising symptoms early, taking precautions to reduce transmission and seeking professional care when required. For health authorities, continued surveillance will help establish whether the high proportion of H1N1 observed in the latest dataset represents a sustained trend or a temporary pattern.